Authors:
PALANGIE T
ASSELAIN B
CAMPANA F
BEUZEBOC P
DIERAS V
DORVAL T
JOUVE M
PIERGA JY
SCHOLL S
POUILLART P
Citation: T. Palangie et al., INITIAL VERSUS DELAYED RADIOTHERAPY COMBINED WITH CONTINUOUS 5-FLUOROURACILE (F), CYCLOPHOSPHAMIDE (C) AND DOXORUBICINE (A) IN INFLAMMATORYBREAST-CANCER (IBC), European journal of cancer, 34, 1998, pp. 64-64
Authors:
ROBAIN M
PIERGA JY
LAURENCE V
JOUVE M
DIERAS V
BEUZEBOC P
PALANGIE T
DORVAL T
SCHOLL S
EXTRA JM
ASSELAIN B
POUILLART P
Citation: M. Robain et al., PREDICTIVE FACTORS OF RESPONSE TO FIRST LINE CHEMOTHERAPY IN METASTATIC BREAST-CANCER (MBC), Annals of oncology, 9, 1998, pp. 71-71
Authors:
PIERGA JY
JOUVE M
ASSELAIN B
LIVARTOWSKI A
BEUZEBOC P
DIERAS V
SCHOLL S
DORVAL T
PALANGIE T
GARCIAGIRALT E
POUILLART P
Citation: Jy. Pierga et al., RANDOMIZED TRIAL COMPARING PROTRACTED INFUSION OF 5-FLUOROURACIL WITHWEEKLY DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH A MONTHLY BOLUS FAC REGIMEN IN METASTATIC BREAST-CARCINOMA (SPM90), British Journal of Cancer, 77(9), 1998, pp. 1474-1479
Authors:
PIERGA JY
JOUVE M
ASSELAIN B
DIERAS V
BEUZEBOC P
PALANGIE T
DORVAL T
GARCIAGIRALT E
SCHOLL S
POUILLART P
Citation: Jy. Pierga et al., RESPONSE TO CHEMOTHERAPY IS THE FIRST PROGNOSTIC FACTOR IN METASTATICBREAST-CANCER, European journal of cancer, 33, 1997, pp. 653-653
Authors:
PIERGA JY
DIERAS V
BEUZEBOC P
DORVAL T
PALANGIE T
JOUVE M
SCHOLL SM
GARCIAGIRALT E
POUILLART P
Citation: Jy. Pierga et al., PHASE-II TRIAL OF DOXORUBICIN, 5-FLUOROURACIL, ETOPOSIDE, AND CISPLATIN IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA, Gynecologic oncology, 66(2), 1997, pp. 246-249
Authors:
ROZAN S
VINCENTSALOMON A
BERNOUX A
VALIDIRE P
ZAFRANI B
JOUVE M
SASTREGARAU X
Citation: S. Rozan et al., CHEMOSENSITIVITY AND THE OUTCOME OF BREAST CANCERS - NO OBSERVED PREDICTIVE VALUE OF C-ERB B-2 EXPRESSION, Laboratory investigation, 76(1), 1997, pp. 123-123
Authors:
JOUVE M
GARCIA MI
COURCOUX P
LABIGNE A
GOUNON P
LEBOUGUENEC C
Citation: M. Jouve et al., ADHESION TO AND INVASION OF HELA-CELLS BY PATHOGENIC ESCHERICHIA-COLICARRYING THE AFA-3 GENE-CLUSTER ARE MEDIATED BY THE AFAE AND AFAD PROTEINS, RESPECTIVELY, Infection and immunity, 65(10), 1997, pp. 4082-4089
Authors:
STOPPALYONNET D
LAURENTPUIG P
ESSIOUX L
PAGES S
ITHIER G
LIGOT L
FOURQUET A
SALMON RJ
CLOUGH KB
POUILLART P
ALAPETITE C
ALEPEE B
KLIJANIENKO J
ASSELAIN B
BEUZEBOC P
BOURGEOIS D
BOURGEOIS H
BOURSTYN E
BRUNIN F
CAMPANA F
CHAUVEINC F
COSSET JM
DECREMOUX P
DELAROCHEFORDIERE A
DELATTRE C
DEMARGERIE V
DESTGAUDENS AB
DIERAS V
DORVAL T
DUBRAY B
DURAND JC
FALCOU MC
FITOUSSI F
GARCIAGIRALT E
GIRAUD P
GAUTIER C
GUGLIELMINA JN
HAMELIN JP
HOFFMAN H
JAULERRY C
JOUVE M
LABETA C
LEGALL M
MAGDELENAT H
MEUNIER M
MOSSERI V
NGUYEN TT
NATALI JC
NEUENSCHWANDER S
NOS C
OLIVIER L
PALANGIE T
PIERGA JY
PONTVERT D
ROGE P
SASTREGAREAU X
SCHLIENGER P
SCHOLL S
SELINGER R
THIBAULT F
THIS P
TROPHILME D
VALIDIRE P
VIELH P
VILCOQ JR
VINCENTSALOMON A
VOILLEMOT N
ZAFRANI B
BONAITIPELLIE C
THOMAS G
Citation: D. Stoppalyonnet et al., BRCA1 SEQUENCE VARIATIONS IN 160 INDIVIDUALS REFERRED TO A BREAST OVARIAN FAMILY CANCER CLINIC/, American journal of human genetics, 60(5), 1997, pp. 1021-1030
Authors:
RAYMOND E
PALANGIE T
JOUVE M
ASSELAIN B
DIERAS V
BEUZEBOC P
DORVAL T
GARCIAGIRALT E
LIVARTOWSKI A
SCHOLL S
POUILLART P
Citation: E. Raymond et al., PROTRACTED CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN COMBINATION WITH DOXORUBICIN, VINCRISTINE, AND ORAL CYCLOPHOSPHAMIDE IN ADVANCED BREAST-CANCER, Cancer investigation, 14(2), 1996, pp. 91-97
Authors:
GARCIAGIRALT E
BEUZEBOC P
DIERAS V
DORVAL T
JOUVE M
LIVARTOWSKI A
PALANGIE T
SCHOLL S
POUILLART P
Citation: E. Garciagiralt et al., PHASE-II TRIAL OF DECAPEPTYL (D-TRP-6), A POTENT LUTEINIZING-HORMONE-RELEASING HORMONE ANALOG IN UNTREATED ADVANCED BREAST-CANCER, American journal of clinical oncology, 19(5), 1996, pp. 455-458
Authors:
PIERGA JY
DIERAS V
PARAISO D
DORVAL T
PALANGIE T
BEUZEBOC P
JOUVE M
SCHOLL SM
GARCIAGIRALT E
POUILLART P
Citation: Jy. Pierga et al., TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA WITH COMBINATION OF ETOPOSIDE, CISPLATIN, AND 5-FLUOROURACIL - A PHASE-II STUDY, Gynecologic oncology, 60(1), 1996, pp. 59-63
Authors:
FIZAZI K
ASSELAIN B
VINCENTSALOMON A
JOUVE M
DIERAS V
PALANGIE T
BEUZEBOC P
DORVAL T
POUILLART P
Citation: K. Fizazi et al., MENINGEAL CARCINOMATOSIS IN PATIENTS WITH BREAST-CARCINOMA - CLINICAL-FEATURES, PROGNOSTIC FACTORS, AND RESULTS OF A HIGH-DOSE INTRATHECAL METHOTREXATE REGIMEN, Cancer, 77(7), 1996, pp. 1315-1323
Authors:
SASTREGARAU X
JOUVE M
ASSELAIN B
VINCENTSALOMON A
BEUZEBOC P
DORVAL T
DURAND JC
FOURQUET A
POUILLART P
Citation: X. Sastregarau et al., INFILTRATING LOBULAR CARCINOMA OF THE BREAST - CLINICOPATHOLOGICAL ANALYSIS OF 975 CASES WITH REFERENCE TO DATA ON CONSERVATIVE THERAPY ANDMETASTATIC PATTERNS, Cancer, 77(1), 1996, pp. 113-120
Authors:
SCHOLL SM
PIERGA JY
ASSELAIN B
BEUZEBOC P
DORVAL T
GARCIAGIRALT E
JOUVE M
PALANGIE T
REMVIKOS Y
DURAND JC
FOURQUET A
POUILLART P
Citation: Sm. Scholl et al., BREAST-TUMOR RESPONSE TO PRIMARY CHEMOTHERAPY PREDICTS LOCAL AND DISTANT CONTROL AS WELL AS SURVIVAL, European journal of cancer, 31A(12), 1995, pp. 1969-1975
Authors:
CALAMITA G
MOLA MG
GOUNON P
JOUVE M
BOURGUET J
SVELTO M
Citation: G. Calamita et al., AQUAPORIN-CHIP-RELATED PROTEIN IN FROG URINARY-BLADDER - LOCALIZATIONBY CONFOCAL MICROSCOPY, The Journal of membrane biology, 143(3), 1995, pp. 267-271
Authors:
PALANGIE T
MOSSERI V
MIHURA J
CAMPANA F
BEUZEBOC P
DORVAL T
GARCIAGIRALT E
JOUVE M
SCHOLL S
ASSELAIN B
POUILLART P
Citation: T. Palangie et al., PROGNOSTIC FACTORS IN INFLAMMATORY BREAST-CANCER AND THERAPEUTIC IMPLICATIONS, European journal of cancer, 30A(7), 1994, pp. 921-927
Authors:
SCHOLL SM
FOURQUET A
ASSELAIN B
PIERGA JY
VILCOQ JR
DURAND JC
DORVAL T
PALANGIE T
JOUVE M
BEUZEBOC P
GARCIOGIRALT E
SALMON RJ
DELAROCHEFORDIERE A
CAMPANA F
POUILLART P
Citation: Sm. Scholl et al., NEOADJUVANT VERSUS ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL PATIENTS WITH TUMORS CONSIDERED TOO LARGE FOR BREAST-CONSERVING SURGERY - PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL - S6, European journal of cancer, 30A(5), 1994, pp. 645-652
Authors:
SPIELMANN M
DORVAL T
TURPIN F
ANTOINE E
JOUVE M
MAYLEVIN F
LACOMBE D
ROUESSE J
POUILLART P
TURSZ T
MERLE S
Citation: M. Spielmann et al., PHASE-II TRIAL OF VINORELBINE DOXORUBICIN AS FIRST-LINE THERAPY OF ADVANCED BREAST-CANCER, Journal of clinical oncology, 12(9), 1994, pp. 1764-1770
Authors:
REMVIKOS Y
JOUVE M
BEUZEBOC P
VIEHL P
MAGDELENAT H
POUILLART P
Citation: Y. Remvikos et al., CELL-CYCLE MODIFICATIONS OF BREAST CANCERS DURING NEOADJUVANT CHEMOTHERAPY - A FLOW-CYTOMETRY STUDY ON FINE-NEEDLE ASPIRATES, European journal of cancer, 29A(13), 1993, pp. 1843-1848
Authors:
BEUZEBOC P
DORVAL T
MATHIEU G
GARCIAGIRALT E
JOUVE M
LIVARTOWSKI A
PALANGIE T
SCHOLL S
POUILLART P
Citation: P. Beuzeboc et al., MALIGNANT SQUAMOUS DEGENERATION OF OVARIAN DERMOID CYSTS - REPORT OF 2 CASES, Annales de chirurgie, 47(7), 1993, pp. 641-644